Sort by
Refine Your Search
- 
                
                
                
Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet
 - 
                
                
                
two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet evolving
 - 
                
                
                
Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet
 - 
                
                
                
a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet evolving
 - 
                
                
                
and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry. Fellows have the
 - 
                
                
                
Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet
 - 
                
                
                
is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet
 - 
                
                
                
-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet evolving
 - 
                
                
                
, a7nAChR, a9* nAChR, GIRK1/2, GIRK1/4etc.). Key initial responsibilities will include biochemical and ADME/PK studies and data analysis, SAR hypothesis generation, empirical and structure-based target design
 - 
                
                
                
orthosteric) and ion channels (a4b2 nAChR, a7nAChR, a9* nAChR, GIRK1/2, GIRK1/4etc.). Key initial responsibilities will include biochemical and ADME/PK studies and data analysis, SAR hypothesis generation